MarketCap
Facebook
X
Telegram
Healthcare Services Group Income Statement 2025-2007 | HCSG
Brief overview of revenue and earnings at Healthcare Services Group
This overview is based on financial performance over the past five years. According to figures from Healthcare Services Group, revenue changed from $1.8 billion to $1.8 billion over five years. The total change was +4.4%, with a CAGR of approximately 0.9%. The business did not achieve meaningful top-line expansion.
Gross profit changed from 268 million dollars to 239 million dollars (−10.7%). Revenue and direct costs changed at similar rates. At the margin level, the figure shifted from 15.2% to 13%. The business retained less gross profit from each unit of revenue.
The operating result measured by EBITDA moved from 14.3 million dollars to 16.8 million dollars, or +17.6%. The operating result outpaced sales and points to improving efficiency. EBITDA margin was 0.8% at the start and 0.9% at the end. The operating margin showed no pronounced shift.
Net profit was $98.7 million at the start and $59.1 million at the end. The decline reduces the quality of the financial trajectory.
Market capitalization changed from 2.4 billion dollars to 1.6 billion dollars (−34.3%). The negative valuation trend points to increased investor caution.
What the figures show
The financial trajectory is weak and requires a cautious interpretation. The positive side is supported by a steady EBITDA margin. The overall view is constrained by a weaker market valuation, weak sales momentum and limited operating profitability. The key question is whether sales can be converted into sustainable profit.
Annual Income Statement Healthcare Services Group
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.56 B | 802 M | 909 M | 1.07 B | 1.36 B | 2.37 B | 1.93 B | 3.21 B | 3.97 B | 2.88 B | 2.54 B | 2.23 B | 1.89 B | 1.63 B | 1.23 B | 877 M | 807 M | 747 M | - |
Shares |
72.4 M | 73.8 M | 74.3 M | 74.3 M | 74.8 M | 74.7 M | 74.4 M | 74 M | 73.4 M | 72.8 M | 71.8 M | 70.6 M | 69.2 M | 67.5 M | 66.6 M | 65.9 M | 65.4 M | 64.7 M | - |
Historical Prices |
21.5 | 10.9 | 12.2 | 14.4 | 18.2 | 31.7 | 24.2 | 40.3 | 50 | 35.4 | 30.8 | 26.8 | 22.5 | 19.6 | 14.7 | 13.3 | 12.3 | 11.6 | 12.8 |
Net Income |
59.1 M | 39.5 M | 38.4 M | 34.2 M | 48.5 M | 98.7 M | 64.6 M | 83.5 M | 88.2 M | 77.4 M | 58 M | 21.8 M | 47.1 M | 44.2 M | 38.2 M | 34.4 M | 30.3 M | 26.6 M | - |
Revenue |
1.84 B | 1.72 B | 1.67 B | 1.69 B | 1.64 B | 1.76 B | 1.84 B | 2.01 B | 1.87 B | 1.56 B | 1.44 B | 1.29 B | 1.15 B | 1.08 B | 889 M | 4.14 M | - | - | - |
Cost of Revenue |
1.6 B | 1.49 B | 1.46 B | 1.5 B | 1.41 B | 1.49 B | 1.61 B | 1.77 B | 1.61 B | 1.34 B | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | 228 M | 237 M | 254 M | 223 M | 201 M | 138 M | 155 M | 147 M | 122 M | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | 3.46 M | 3.09 M | 1.36 M | - | - | - | - | - | - | - | - | - | - |
EBITDA |
16.8 M | 14.6 M | 14.3 M | 15.3 M | 14.7 M | 14.3 M | 91.8 M | 110 M | 136 M | 125 M | 96.7 M | 37.3 M | 69 M | 72.5 M | 61.2 M | 3.76 M | 3.23 M | 2.85 M | - |
Operating Expenses |
- | - | - | - | - | - | 150 M | 137 M | 127 M | 105 M | 112 M | 108 M | 92 M | 79.3 M | 65.3 M | - | - | - | - |
General and Administrative Expenses |
191 M | 183 M | 167 M | 140 M | 173 M | 151 M | 150 M | 137 M | 127 M | 105 M | 112 M | 108 M | 92 M | 79.3 M | 65.3 M | 57.3 M | 50.3 M | 39.5 M | - |
All numbers in USD currency
Quarterly Income Statement Healthcare Services Group
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
68.8 M | 69.9 M | 69.6 M | 72.2 M | 73.2 M | 73.7 M | 73.2 M | 73.7 M | 73.9 M | 73.9 M | 73.3 M | 74.4 M | 74.5 M | 74.5 M | 74.1 M | 74.3 M | 74.3 M | 74.3 M | 73.8 M | 74.9 M | 75 M | 75 M | 74.5 M | 74.7 M | 74.7 M | 74.7 M | 74.1 M | 74.4 M | 74.4 M | 74.3 M | 73.9 M | 74 M | 74 M | 73.9 M | 73.4 M | 73.5 M | 73.3 M | 73.1 M | 72.6 M | 72.8 M | 72.6 M | 72.4 M | 72 M | 72 M | 71.7 M | 71.5 M | 72.9 M | 70.7 M | 70.4 M | 70.3 M | 71.9 M | 69.7 M | 68.6 M | 68.5 M | 70 M | 67.7 M | 67.3 M | 67.1 M | - | 66.7 M | 66.5 M | 66.4 M | 44 M | 44 M |
Net Income |
22.7 M | 26.1 M | - | 43 M | -32.4 M | 17.2 M | - | 14 M | -1.79 M | 15.3 M | - | -5.05 M | 8.25 M | 11.7 M | - | 322 K | 6.82 M | 11.3 M | - | 9.54 M | 9.56 M | 24.7 M | - | 27.6 M | 23.1 M | 20.2 M | 18.9 M | 18.3 M | 18.2 M | 9.16 M | 31.6 M | 26.1 M | 25.8 M | 72 K | 20.2 M | 23.5 M | 22.6 M | 22 M | 20.3 M | 19.7 M | 18.8 M | 18.6 M | 9.13 M | 17.1 M | 16.3 M | 15.5 M | 15.5 M | -22.2 M | 13.9 M | 14.6 M | 5.45 M | 13.8 M | 12.9 M | 15 M | 12.8 M | 11.5 M | 11.3 M | 8.58 M | 10.6 M | 10 M | 9.83 M | 7.77 M | 9.17 M | 8.72 M |
Revenue |
471 M | 463 M | - | 464 M | 458 M | 448 M | - | 428 M | 426 M | 423 M | - | 411 M | 419 M | 417 M | - | 414 M | 425 M | 427 M | - | 416 M | 398 M | 408 M | - | 436 M | 452 M | 449 M | 447 M | 456 M | 462 M | 476 M | 495 M | 506 M | 502 M | 501 M | 499 M | 491 M | 471 M | 404 M | 399 M | 393 M | 387 M | 385 M | 366 M | 360 M | 355 M | 355 M | 342 M | 320 M | 319 M | 312 M | 304 M | 299 M | 274 M | 274 M | 277 M | 273 M | 267 M | 261 M | 250 M | 219 M | 212 M | 208 M | - | - |
Cost of Revenue |
396 M | 387 M | - | 368 M | 456 M | 380 M | - | 365 M | 385 M | 359 M | - | 377 M | 368 M | 362 M | - | 377 M | 379 M | 373 M | - | 365 M | 336 M | 337 M | - | 365 M | 388 M | 387 M | - | 398 M | 400 M | 427 M | - | 438 M | 436 M | 469 M | - | 427 M | 407 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
7.33 M | 3.81 M | - | 3.4 M | 3.2 M | 3.88 M | - | 3.1 M | 3 M | 3.53 M | - | 2.5 M | 2.4 M | 3.72 M | - | 2.6 M | 2.4 M | 4.15 M | - | 11 M | 2.6 M | 3.61 M | - | 10.8 M | 7.15 M | 3.56 M | - | 10.4 M | 7 M | 3.49 M | - | 7.02 M | 4.84 M | 2.41 M | - | 6.34 M | 4.24 M | 1.89 M | - | 5.63 M | 3.91 M | 1.96 M | - | 5.68 M | 3.83 M | 1.91 M | - | 5.31 M | 3.58 M | 1.76 M | - | 4.49 M | 2.71 M | 1.35 M | - | 3.77 M | 2.53 M | 1.25 M | - | 3.12 M | 2.05 M | 1 M | 2.72 M | 1.84 M |
General and Administrative Expenses |
52.6 M | 42 M | - | 50.5 M | 49.2 M | 45 M | - | 46.9 M | 44.4 M | 46.9 M | - | 39 M | 41.4 M | 40 M | - | 35.8 M | 29.3 M | 35.7 M | - | 38.8 M | 50.1 M | 40 M | - | 37.3 M | 41.5 M | 30 M | - | 33.5 M | 38.6 M | 41.1 M | - | 36.7 M | 34.1 M | 33.8 M | - | 32.9 M | 32 M | 28.2 M | - | 27.2 M | 25.7 M | 25.3 M | - | 23.4 M | 25.1 M | 26.8 M | - | 39.4 M | 22.2 M | 22 M | - | 22.6 M | 19.4 M | 20.8 M | - | 20.8 M | 18.5 M | 21 M | - | 14.3 M | 15.5 M | 16.8 M | 14.5 M | 13.2 M |
All numbers in USD currency
The income statement is one of the three key financial reports of a company Healthcare Services Group (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
China
USA
Russia
Germany
Britain
